[Pefloxacin (Abaktal)--efficacy in treating severe infections, optimization of treatment based on pharmacokinetic and pharmacodynamic parameters].
Budanov
S V
SV
Research Centre of Drug Evaluation, National Research Centre of Antibiotics, Moscow.
Vasil'ev
A N
AN
Smirnov
L B
LB
D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D015366:Pefloxacin / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D015366:Pefloxacin